Comerica Bank’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.84M | Sell |
28,970
-4,386
| -13% | -$273K | 0.01% | 1159 |
|
|
2025
Q3 | $1.83M | Sell |
33,356
-2,904
| -8% | -$120K | 0.01% | 1207 |
|
|
2025
Q2 | $1.2M | Sell |
36,260
-206,849
| -85% | -$7.19M | ﹤0.01% | 1425 |
|
|
2025
Q1 | $9.77M | Buy |
243,109
+7,645
| +3% | +$351K | 0.04% | 407 |
|
|
2024
Q4 | $11.1M | Sell |
235,464
-1,558
| -0.7% | -$80.9K | 0.04% | 383 |
|
|
2024
Q3 | $12.5M | Buy |
237,022
+70,842
| +43% | +$3.95M | 0.05% | 358 |
|
|
2024
Q2 | $9M | Buy |
166,180
+35,374
| +27% | +$2.14M | 0.04% | 430 |
|
|
2024
Q1 | $9.17M | Buy |
130,806
+84,967
| +185% | +$6.57M | 0.04% | 445 |
|
|
2023
Q4 | $3.83M | Buy |
45,839
+940
| +2% | +$34K | 0.02% | 828 |
|
|
2023
Q3 | $1.32M | Buy |
+44,899
| New | +$1.5M | 0.01% | 1289 |
|
|
2022
Q4 | $2.4M | Sell |
56,094
-15,935
| -22% | -$686K | 0.02% | 978 |
|
|
2022
Q3 | $3.25M | Sell |
72,029
-955
| -1% | -$46K | 0.03% | 741 |
|
|
2022
Q2 | $2.92M | Buy |
72,984
+2,267
| +3% | +$91.3K | 0.02% | 842 |
|
|
2022
Q1 | $2.67M | Buy |
70,717
+905
| +1% | +$32.2K | 0.02% | 968 |
|
|
2021
Q4 | $2.13M | Sell |
69,812
-5,743
| -8% | -$222K | 0.02% | 1120 |
|
|
2021
Q3 | $2.8M | Buy |
75,555
+8,645
| +13% | +$255K | 0.02% | 1073 |
|
|
2021
Q2 | $2.01M | Sell |
66,910
-4,720
| -7% | -$111K | 0.01% | 1310 |
|
|
2021
Q1 | $1.9M | Sell |
71,630
-2,373
| -3% | -$50.7K | 0.01% | 1383 |
|
|
2020
Q4 | $1.51M | Buy |
74,003
+475
| +0.6% | +$8.68K | 0.01% | 1478 |
|
|
2020
Q3 | $1.21M | Buy |
73,528
+10,834
| +17% | +$253K | 0.01% | 1445 |
|
|
2020
Q2 | $1.5M | Buy |
62,694
+5,471
| +10% | +$103K | 0.01% | 1262 |
|
|
2020
Q1 | $897K | Buy |
57,223
+2,159
| +4% | +$27.5K | 0.01% | 1417 |
|
|
2019
Q4 | $708K | Buy |
55,064
+295
| +0.5% | +$3.03K | 0.01% | 1733 |
|
|
2019
Q3 | $608K | Buy |
54,769
+944
| +2% | +$11.8K | ﹤0.01% | 1790 |
|
|
2019
Q2 | $624K | Sell |
53,825
-329
| -0.6% | -$3.17K | 0.01% | 1784 |
|
|
2019
Q1 | $472K | Buy |
54,154
+1,808
| +3% | +$13.3K | ﹤0.01% | 1906 |
|
|
2018
Q4 | $357K | Sell |
52,346
-228
| -0.4% | -$1.67K | ﹤0.01% | 1996 |
|
|
2018
Q3 | $380K | Sell |
52,574
-521
| -1% | -$4.18K | ﹤0.01% | 1992 |
|
|
2018
Q2 | $467K | Buy |
53,095
+609
| +1% | +$5.07K | ﹤0.01% | 1950 |
|
|
2018
Q1 | $373K | Buy |
52,486
+998
| +2% | +$8.56K | ﹤0.01% | 2003 |
|
|
2017
Q4 | $499K | Sell |
51,488
-1,566
| -3% | -$17.8K | ﹤0.01% | 1928 |
|
|
2017
Q3 | $737K | Buy |
53,054
+5,192
| +11% | +$70.9K | 0.01% | 1748 |
|
|
2017
Q2 | $689K | Buy |
+47,862
| New | +$665K | 0.01% | 1728 |
|
Other funds holding CYTK
DTC
RI
Comerica Bank's CYTK Position: Q4 2025 in Review
Comerica Bank reduced its Cytokinetics (CYTK) stake by 13% in Q4 2025, selling an estimated $273K and leaving 28,970 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #1159.
Comerica Bank first reported a position in CYTK in Q2 2017 and has held it in 33 quarters since. The position peaked at $12.5M in Q3 2024. 430 funds tracked by Wall St. Rank hold CYTK as of Q4 2025.
- Comerica Bank held 28,970 shares of Cytokinetics worth $1.84M as of Q4 2025.
- Comerica Bank sold 4,386 Cytokinetics shares in Q4 2025, an estimated $273K.
- Cytokinetics made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1159 holding.
- Comerica Bank first reported a position in Cytokinetics in Q2 2017 and has held it in 33 quarters since.
- Comerica Bank's Cytokinetics position peaked at $12.5M in Q3 2024.
- 430 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.